Who funds diabetes research?

We count 246 funded diabetes projects, active between 2019 and 2033, from 7 funders. The most came from EU · ERC (40 projects), Wellcome (40 projects) and EU · MSCA (37 projects). The median award is $2.5M, across the 223 of 246 projects that list an amount.

Funded projects

246

Funders

7

Median award

$2.5M

Open calls now

9

Top funders of diabetes research

Projects whose title or summary mentions diabetes. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.

Open diabetes funding calls

9 open calls mention diabetes today.

• Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: November 9, 2026 ·
• Diabetes Research Centers (P30 Clinical Trial Optional)
  National Institutes of HealthUp to $1,000,000Deadline: January 27, 2027 ·
• Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
  National Institutes of HealthUp to $500,000Deadline: March 10, 2027 ·
• Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
  National Institutes of HealthNot specifiedDeadline: November 5, 2027 ·
  Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)
• Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: January 6, 2028 ·
  Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)
• Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
  National Institutes of HealthUp to $500,000Deadline: January 7, 2028 ·
  Real odds: About 1 in 8 funded (13% · NIH R01-equivalent grants, all NIH institutes, FY2025)
• Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedDeadline: January 7, 2028 ·
  Real odds: About 1 in 9 funded (11% · NIH R21 (exploratory/developmental), all NIH institutes, FY2025)
• Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
  National Institutes of HealthUp to $75,000Deadline: January 7, 2028 ·
• Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
  National Institutes of HealthUp to $2,100,000Deadline: May 26, 2028 ·

Real odds

• About 1 in 8 funded · 13% · NIH R01-equivalent grants, all NIH institutes, FY2025 · NIH Data Book, report 29
• About 1 in 9 funded · 11% · NIH R21 (exploratory/developmental), all NIH institutes, FY2025 · NIH Data Book, report 202

Published success rates for the programs behind the open calls above: the share of applications the funder funded, program-wide, not for this topic.

Forecast: announced, not open yet

8 forecast calls on diabetes. Funders publish forecasts before a call opens; you can't apply to these yet, and dates can change.

• ForecastMultimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed)
  National Institutes of HealthNot specifiedExpected to open December 1, 2026
• ForecastImplementation Research on Multi-component Community-Clinical Linkage Approaches for Diabetes Prevention and Management
  Centers for Disease Control and Prevention - ERA$500,000 – $725,000Expected to open January 21, 2027
• ForecastSingle Source Competition for Continuation of Understanding and Targeting the Pathophysiology of Youth-Onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed)
  National Institutes of HealthNot specifiedExpected to open February 2, 2027
• ForecastThe Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes
  National Institutes of HealthNot specifiedExpected to open July 15, 2027
• ForecastThe NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers
  National Institutes of HealthNot specifiedExpected to open August 1, 2026
• ForecastThe NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center
  National Institutes of HealthNot specifiedExpected to open August 1, 2026
• ForecastThe NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
  National Institutes of HealthNot specifiedExpected to open August 1, 2026
• ForecastThe NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
  National Institutes of HealthNot specifiedExpected to open August 1, 2026

Funded diabetes projects

A sample, latest start first, at most three per program.

• The Principles of Centriole and Centrosome Biogenesis
  Wellcome · £3,474,235 · ends 2033
• Investigating neural fine-tuning of pancreatic islet physiology in health and disease
  Wellcome · £2,073,272 · ends 2033
• Towards a type 2 diabetes precision diagnosis approach with glycated haemoglobin (HbA1c) measurement
  Wellcome · £4,940,184 · ends 2032
• CAREER: Nutrition Chatbots: Advancing Nutritional Health and Dietary Counseling Through Human-AI Collaboration
  NSF · CISE · $679,084 · ends 2031
• West Virginia Rural Roots to Research
  NIH · Office of the Director · $3,697,994 · ends 2031
• CAREER: Integrating the chemistry and biological organization of neuroactive alkaloid biosynthesis
  NSF · BIO · $1,599,999 · ends 2031
• BRF: Developing Multidisciplinary and Collaborative Research Spaces to Grow Biomedical Research Capacity at the University of Arkansas
  NIH · Office of the Director · $8,000,000 · ends 2031
• Ultraprocessed foods: mechanisms of harm and harm reduction
  UKRI · MRC · £2,672,836 · ends 2031
• Obesity, diabetes and hypertension during pregnancy significantly increase morbidity in pregnant women and the risks of metabolic diseases…
  USDA · $630,435 · ends 2031
• Mechanisms for population strategies to prevent diet- and activity-related chronic disease
  UKRI · MRC · £2,407,243 · ends 2030

How we count

Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “diabetes”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.